SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001179110-15-014821
Filing Date
2015-11-13
Accepted
2015-11-13 11:20:59
Documents
1
Period of Report
2015-11-10

Document Format Files

Seq Description Document Type Size
1 FORM 4/A - edgar.html 4/A  
1 FORM 4/A - edgar.xml 4/A 5693
  Complete submission text file 0001179110-15-014821.txt   6910
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SYNTA PHARMACEUTICALS CORP. 45 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Gollust Keith R (Reporting) CIK: 0001325712 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-33277 | Film No.: 151227683